Interestingly, in this study, HS maintained electrolyte levels (Na+ and K+) within the baseline range, suggesting that HS compounds may directly or indirectly be effective in managing cardiac dysfunction in CKD through selective ACE inhibition and the regulation of ACE and electrolyte interactions. Here, ACE is linked to chronic kidney disease.